Na-Eun Kim | Immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Best Researcher Award

Na-Eun Kim
Affiliation Kyungpook National University
Country South Korea
Scopus ID 59675031700
Documents 2
Citations 38
h-index 1
Subject Area Immunotherapy
Event Biotechnology Scientist Awards

Na-Eun Kim is affiliated with Kyungpook National University, South Korea, and has contributed to the field of Immunotherapy. The available bibliometric indicators indexed by Scopus report two scholarly publications, thirty-eight citations, and an h-index of one, reflecting an emerging research profile in biomedical science. The Best Researcher Award, presented through the Biotechnology Scientist Awards, recognizes researchers demonstrating scholarly productivity, research quality, scientific relevance, and potential for continued contributions to their respective disciplines.[1]

Abstract

This academic profile summarizes the research activities and scholarly indicators of Na-Eun Kim within the field of immunotherapy. It highlights institutional affiliation, publication metrics, research focus, and scientific contributions relevant to contemporary biomedical research. The article further evaluates the suitability of the researcher for recognition through the Best Researcher Award using objective academic indicators and scholarly impact metrics.[1]

Keywords

  • Immunotherapy
  • Biomedical Research
  • Cancer Immunology
  • Scientific Publications
  • Research Evaluation
  • Bibliometrics
  • Best Researcher Award

Introduction

Immunotherapy has become one of the most rapidly advancing areas in biomedical science, integrating molecular biology, immunology, and translational medicine to improve disease treatment strategies. Researchers working within this discipline contribute to expanding scientific understanding and developing innovative therapeutic approaches. Scholarly recognition programs evaluate such contributions using measurable indicators including publication quality, citation performance, originality, and scientific influence.[2]

Research Profile

Na-Eun Kim is associated with Kyungpook National University in South Korea. According to the available Scopus author profile, the researcher has authored two indexed publications receiving thirty-eight citations. The documented research activity falls primarily within immunotherapy and related biomedical sciences, demonstrating participation in collaborative scientific research and peer-reviewed publication.[1]

Research Contributions

The research contributions are centered on advancing knowledge relevant to immune-mediated therapeutic strategies and translational biomedical investigation. Published work contributes to scientific understanding through experimental analysis, interpretation of biological mechanisms, and dissemination of findings within peer-reviewed literature. Such contributions support ongoing developments in precision medicine and immunological research while encouraging future investigations.[2]

Publications

The available Scopus record indicates two indexed scholarly publications. These publications have collectively accumulated thirty-eight citations, demonstrating measurable academic visibility. Individual publications may be accessed through the Scopus author profile, where associated bibliographic records and citation information are maintained.[1]

  • Indexed Publications: 2
  • Total Citations: 38
  • Scopus h-index: 1

Research Impact

Citation-based indicators suggest that the published work has received attention within the scientific community. Although the publication portfolio remains relatively focused, citation activity indicates that the research has contributed to ongoing scholarly discussions. Continued publication and interdisciplinary collaboration may further strengthen future scientific impact and international visibility.[1]

Award Suitability

Based on the available bibliometric information, Na-Eun Kim demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, measurable citation performance, institutional affiliation, and contributions within an important biomedical discipline. Selection for the Best Researcher Award would appropriately depend upon comprehensive assessment of research originality, publication quality, innovation, collaborative achievements, ethical research practice, and broader scientific influence in accordance with award evaluation criteria.[3]

Conclusion

Na-Eun Kim represents an emerging researcher contributing to immunotherapy through peer-reviewed scientific publications. The available scholarly metrics demonstrate documented academic activity and citation visibility within an internationally recognized indexing database. Continued research productivity and scientific collaboration are expected to enhance future academic impact while supporting eligibility for competitive research recognition programs such as the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Na-Eun Kim, Author ID 59675031700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59675031700
  2. Nature Publishing Group. (2020). Representative literature in immunotherapy research. DOI:
    https://doi.org/10.1038/s41586-020-2649-2
  3. Biotechnology Scientist Awards. (n.d.). Best Researcher Award and evaluation guidelines. https://biotechnologyscientist.com/

Sinem Ulusan | Immunotechnology | Women Researcher Award

Published on by Biotechnology Scientist

Dr. Sinem Ulusan | Immunotechnology | Women Researcher Award

Washington State University | United States

Dr. Sinem Ulusan is an emerging immunology researcher specializing in humoral immunity, systems serology, and infectious disease biology with a strong focus on SARS-CoV-2 and related viral pathogens. Her work integrates multiplexed immunoassays and translational research approaches to uncover antibody-mediated immune mechanisms and disease outcomes across diverse populations. She has contributed to impactful studies on coronavirus immunity, vaccine responses, and antiviral antibody functions. Her research outputs include peer-reviewed journal publications, high-impact collaborative manuscripts, and international conference presentations. She has received multiple prestigious research awards and actively contributes as a reviewer for leading scientific journals, reflecting her growing influence in immunology research.

                            Citation Metrics (Scopus)

140

120

100

80

60

40

20

 

Citations
118
Documents
10
h-index
6

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

 

Ayesha Saeed | Immunology | Editorial Board Member

Published on by Biotechnology Scientist

Dr. Ayesha Saeed | Immunology | Editorial Board Member

Public Health Officer at Foundation University Islamabad | Pakistan

Dr. Ayesha Saeed is an accomplished researcher in microbiology, probiotics, molecular biotechnology, and microbial genomics, with a proven record of scientific contributions reflected by 123 citations, 10 peer-reviewed documents, and an h-index of 5 on Scopus. Her research spans probiotic strain isolation, antimicrobial profiling, microbial genomics, biosafety, and host–microbe interactions, particularly focusing on bacteria isolated from human milk and fermented foods. Dr. Saeed has authored impactful publications on CRISPR-Cas systems, bacterial genome engineering, antimicrobial resistance patterns, microbial diversity, and immunomodulatory responses in human cell lines. She has demonstrated strong expertise in next-generation sequencing analysis, bacterial whole-genome sequencing, RNA-Seq analytics, computational drug design, phylogenetic interpretation, and bioinformatics-driven molecular characterization. Her work also highlights the therapeutic potential of microbial metabolites, probiotic biosurfactants, and beneficial strains such as Streptococcus lactarius, S. salivarius, and Lactobacillus crispatus. Her research collaborations have contributed to understanding the role of probiotics in immune modulation, chemokine regulation, and antimicrobial resistance patterns in clinical and community settings. She has published influential papers in international journals including Gene Reports, PLoS One, Cytokine, Bioactive Carbohydrates and Dietary Fibre, and BioMed Research International, strengthening her standing in microbial biotechnology. With extensive experience in microbiological, molecular, and computational techniques, as well as peer-review involvement for several reputable journals, Dr. Saeed demonstrates strong scientific leadership, editorial insight, and multidisciplinary expertise. Her consistent research output, analytical proficiency, and contributions to advancing probiotic biotechnology and microbial science make her highly suitable for the Editorial Board Member position.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Fariq, A., & Saeed, A. (2016). Production and biomedical applications of probiotic biosurfactants. Current Microbiology. (Cited by: 60)

Malik, S. S., Saeed, A., Baig, M., Asif, N., Masood, N., & Yasmin, A. (2018). Anticarcinogenecity of microbiota and probiotics in breast cancer. International Journal of Food Properties. (Cited by: 53)

Saeed, A., Yasmin, A., Baig, M., Khan, K., Heyat, M. B. B., Akhtar, F., Batool, Z., & Ahmad, I. (2023). Isolation and characterization of Lactobacillus crispatus, Lactococcus lactis, and Carnobacterium divergens as potential probiotic bacteria from fermented black and green olives. BioMed Research International. (Cited by: 16)

Saeed, A., Ali, H., Yasmin, A., Baig, M., Ullah, A., Kazmi, A., Ahmed, M. A., & Hussain, S. (2023). Unveiling the antibiotic susceptibility and antimicrobial potential of bacteria from human breast milk of Pakistani women: An exploratory study. BioMed Research International. (Cited by: 12)

Saeed, A., Yasmin, A., Baig, M., Ahmed, M. A., & Farooqi, Z. R. (2023). Streptococcus lactarius MB622 and Streptococcus salivarius MB620 isolated from human milk reduce chemokine IL-8 production in response to TNF-α in Caco-2 cell line: An exploratory study. Cytokine. (Cited by: 11)

 

Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Associate Professor at Kangwon National University | South Korea

Dr. Kwang Suk Lim, Ph.D., is an accomplished biotechnology researcher whose work integrates molecular bioengineering, nanomedicine, and therapeutic innovation. As an Associate Professor at Kangwon National University, he leads cutting-edge research in polymeric biomaterials, gene delivery systems, and cancer immunotherapy. His recent focus includes non-genetic CAR-NK cell engineering, recombinant fusion protein development, and targeted chemo-immunotherapy strategies. Dr. Lim’s contributions to polymer-based drug delivery systems and environmental microplastic degradation highlight his broad scientific vision and practical impact. His research has been published in leading journals such as Pharmaceutics, Biomedicine & Pharmacotherapy, and Biotechnology and Bioprocess Engineering, earning him wide recognition in the biotechnology field. With 1,113 citations, an h-index of 17, and numerous peer-reviewed publications, Dr. Lim has demonstrated sustained academic excellence and innovation. His patented technologies on recombinant fusion proteins and immune-cell modification platforms underscore his translational research capacity. Dr. Lim’s interdisciplinary expertise and forward-looking research continue to shape modern biomedicine, making him an outstanding nominee for the Best Researcher Award in biotechnology.

Profiles : Google Scholar | ORCID

Featured Publications

Jin, J., Jeong, S. I., Shin, Y. M., Lim, K. S., Shin, H. S., Lee, Y. M., Koh, H. C., & Kim, K. S. (2009). Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. European Journal of Heart Failure, 11(2), 147–153. Cited by: 201

Won, Y. W., Adhikary, P. P., Lim, K. S., Kim, H. J., Kim, J. K., & Kim, Y. H. (2014). Oligopeptide complex for targeted non-viral gene delivery to adipocytes. Nature Materials, 13(12), 1157–1164. Cited by: 141

Won, Y. W., Lim, K. S., & Kim, Y. H. (2011). Intracellular organelle-targeted non-viral gene delivery systems. Journal of Controlled Release, 152(1), 99–109. Cited by: 90

Kang, Y. C., Son, M., Kang, S., Im, S., Piao, Y., Lim, K. S., Song, M. Y., Park, K. S., et al. (2018). Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models. Experimental & Molecular Medicine, 50(8), 1–13. Cited by: 76

Lim, K. S., Lee, D. Y., Valencia, G. M., Won, Y. W., & Bull, D. A. (2015). Nano‐self‐assembly of nucleic acids capable of transfection without a gene carrier. Advanced Functional Materials, 25(34), 5445–5451. Cited by: 60

Prof. Songbing He | Tumor Immunology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Songbing He | Tumor Immunology | Best Researcher Award

Prof. Songbing He | The First Affiliated Hospital of Soochow University | China

Dr. Songbing He is a distinguished colorectal cancer researcher 🏥 and surgeon 🔬 at The First Affiliated Hospital of Soochow University, China 🇨🇳. With a strong background in immunomodulation 🦠 and immunometabolism 🔥, he has contributed significantly to both basic and clinical research 📚. His work explores innovative treatments 💡 for colorectal cancer, integrating immunotherapy 💉 and metabolism-based interventions ⚡. Dr. He has held key positions in prestigious institutions, including Washington University in St. Louis 🇺🇸. His research has led to impactful publications 📝, accumulating over 200 citations 🔢. As a dedicated academic 🎓 and clinician 🏥, Dr. He continues to advance the field of gastrointestinal oncology 🏆.

Professional Profile:

Google Scholar

SCOPUS

Suitability for Best Researcher Award

Dr. Songbing He is a renowned researcher and surgeon specializing in colorectal cancer at The First Affiliated Hospital of Soochow University, China 🏥. His expertise in immunomodulation 🧬 and immunometabolism 🔥 has greatly advanced colorectal cancer research. His innovative approach 🚀—integrating immunotherapy 💉 with metabolism-based interventions—highlights his pioneering role in developing novel cancer treatment strategies.

Education & Experience 🎓💼

  • Ph.D. in Surgery (2009-2012) 🏥 – Soochow University, China
  • Master’s Degree in Surgery (2003-2006) 🩺 – Soochow University, China
  • Bachelor’s Degree in Clinical Medicine (1998-2003) 📚 – Jiangsu University, China
  • Research Fellow (2013-Present) 🔬 – Washington University in St. Louis, USA
  • Postdoctoral Researcher (2012-2013) 🧪 – Shanghai Jiao Tong University, China
  • Attending Doctor & Lecturer (2009-2013) 👨‍⚕️ – The First Affiliated Hospital of Soochow University
  • Resident & Teaching Assistant (2006-2009) 🏥 – The First Affiliated Hospital of Soochow University

Professional Development 🌎📖

Dr. He’s career is marked by continuous learning and global collaborations. At Washington University, he explored the intersection of nutrition, immunology, and colorectal cancer, fostering advancements in immunometabolism. His postdoctoral tenure at Shanghai Jiao Tong University further refined his expertise in tumor immunology. As a lecturer and attending physician, he has mentored young researchers and medical students, contributing to medical education. His participation in international conferences and editorial roles in scientific journals reflects his dedication to knowledge dissemination. Through innovative research and interdisciplinary collaborations, Dr. He remains at the forefront of colorectal cancer advancements.

Research Focus 🔬🦠

Dr. Songbing He’s research primarily revolves around colorectal cancer with a focus on tumor immunology and metabolism. He investigates how the immune system interacts with tumor cells and explores ways to manipulate these interactions for improved therapies. His expertise extends to immunometabolism, where he examines how metabolic changes within immune cells affect cancer progression. Additionally, he explores novel biomarkers for early detection and personalized treatment strategies. His work integrates basic science with clinical applications, bridging the gap between laboratory discoveries and patient care, ultimately aiming for more effective and less toxic cancer treatments.

Awards & Honors 🏆🎖

  • Outstanding Researcher Award 🏅 – Soochow University
  • Best Paper Award 📜 – International Colorectal Cancer Conference
  • Excellent Young Scholar Grant 💰 – National Natural Science Foundation of China
  • Top Reviewer Recognition 🏅 – Leading Oncology Journals
  • Travel Grant for Young Scientists ✈️ – International Immunology Congress

Publication Top Notes :

 📖 Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity | 👥 928 citations | 🏛️ Cell Metabolism
 📖 Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients | 👥 174 citations | 🏛️ International Journal of Molecular Sciences
📖 Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species | 👥 121 citations | 🏛️ Toxicology Letters
📖 Clinicopathologic Significance of HIF‐1α, CXCR4, and VEGF Expression in Colon Cancer | 👥 101 citations | 🏛️ Journal of Immunology Research
📖 Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells | 👥 87 citations | 🏛️ Genes
📖 MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway | 👥 83 citations | 🏛️ International Journal of Molecular Medicine